IDEAS home Printed from https://ideas.repec.org/f/pgr520.html
   My authors  Follow this author

Johann Matthias Graf von der Schulenburg

Personal Details

First Name:Johann
Middle Name:Matthias
Last Name:Graf von der Schulenburg
Suffix:
RePEc Short-ID:pgr520
[This author has chosen not to make the email address public]
Schleiermacherstrasse 24 30625 Hannover Germany
+491633988889

Affiliation

Wirtschaftswissenschaftliche Fakultät
Leibniz Universität Hannover

Hannover, Germany
http://www.wiwi.uni-hannover.de/
RePEc:edi:fwhande (more details at EDIRC)

Research output

as
Jump to: Working papers Articles Books Editorship

Working papers

  1. F.S. Mennini & A. Marcellusi & J.M. Graf von Der Schulenburg & A. Gray & Pierre Lévy & P. Sciattella & M. Soro & G. Staffiero & J. Zeidler & A. Maggioni & R. E. Schmieder, 2015. "Cost of poor adherence to anti-hypertensive therapy in five European countries," Post-Print hal-01616348, HAL.
  2. Neubauer, Sarah & Zeidler, Jan & Lange, Ansgar & Graf von der Schulenburg, J.-Matthias, 2014. "Grundlagen und Methoden von GKV-Routinedatenstudien," Hannover Economic Papers (HEP) dp-534, Leibniz Universität Hannover, Wirtschaftswissenschaftliche Fakultät.
  3. Francesco Saverio Mennini & Andrea Marcellusi & J.Matthias Graf von der Schulenburg & Alastair Gray & Pierre L. Levy & Paolo Sciattella & Marco Soro & Gianandrea Staffiero & Jan Zeidler & Aldo Maggion, 2013. "Cost of Poor Adherence to Anti-Hypertensive Therapy in Europe," CEIS Research Paper 299, Tor Vergata University, CEIS, revised 13 Dec 2013.

Articles

  1. Christoph Schwarzbach & Theresa Eden & Oliver Werth & Ute Lohse & Michael H. Breitner & Johann-Matthias Graf von der Schulenburg, 2023. "Digital Transformation in Back-Offices of German Insurance Companies," International Journal of Innovation and Technology Management (IJITM), World Scientific Publishing Co. Pte. Ltd., vol. 20(08), pages 1-27, December.
  2. Dabbous, Monique & Toumi, Mondher & Simoens, Steven & Wasem, Juergen & Saal, Gauri & Wang, Yitong & Osuna, José Luis Huerta & François, Clément & Annemans, Lieven & Graf von der Schulenburg, Johann-Ma, 2022. "Amortization of gene replacement therapies: A health policy analysis exploring a mechanism for mitigating budget impact of high-cost treatments," Health Policy, Elsevier, vol. 126(1), pages 49-59.
  3. J.-Matthias Graf von der Schulenburg, 2021. "COVID-19: not the time for health economists? A plea for more proactive health economic involvement," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(7), pages 1001-1004, September.
  4. Doug Coyle & Isabelle Durand-Zaleski & Jasmine Farrington & Louis Garrison & Johann-Matthias Graf von der Schulenburg & Wolfgang Greiner & Louise Longworth & Aurélie Meunier & Anne-Sophie Moutié & Ste, 2020. "HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(9), pages 1421-1437, December.
  5. Dirk Wrede & Tino Stegen & Johann-Matthias Schulenburg, 2020. "Affirmative and silent cyber coverage in traditional insurance policies: Qualitative content analysis of selected insurance products from the German insurance market," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 45(4), pages 657-689, October.
  6. Dirk Wrede & Annemarie Will & Tim Linderkamp & Johann-Matthias Graf Schulenburg, 2019. "Correction to: An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 44(2), pages 357-358, April.
  7. Thomas R. Staab & Miriam Walter & Sonja Mariotti Nesurini & Charalabos-Markos Dintsios & J.-Matthias Graf von der Schulenburg & Volker E. Amelung & Jörg Ruof, 2018. "“Market withdrawals” of medicines in Germany after AMNOG: a comparison of HTA ratings and clinical guideline recommendations," Health Economics Review, Springer, vol. 8(1), pages 1-11, December.
  8. Kristina Ludwig & J.-Matthias Graf von der Schulenburg & Wolfgang Greiner, 2018. "German Value Set for the EQ-5D-5L," PharmacoEconomics, Springer, vol. 36(6), pages 663-674, June.
  9. Dirk Wrede & Annemarie Will & Tim Linderkamp & Johann-Matthias Graf Schulenburg, 2017. "An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 42(4), pages 633-656, October.
  10. I. Aumann & M. Treskova & N. Hagemann & J.-M. Schulenburg, 2016. "Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany," Applied Health Economics and Health Policy, Springer, vol. 14(4), pages 441-452, August.
  11. Katharina Schmidt & Ana Babac & Frédéric Pauer & Kathrin Damm & J-Matthias von der Schulenburg, 2016. "Measuring patients’ priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks," Health Economics Review, Springer, vol. 6(1), pages 1-11, December.
  12. A. Kuhlmann & T. Schmidt & M. Treskova & J. López-Bastida & R. Linertová & J. Oliva-Moreno & P. Serrano-Aguilar & M. Posada-de-la-Paz & P. Kanavos & D. Taruscio & A. Schieppati & G. Iskrov & M. Péntek, 2016. "Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 79-87, April.
  13. Ulrike Theidel & J-Matthias Graf von der Schulenburg, 2016. "Benefit assessment in Germany: implications for price discounts," Health Economics Review, Springer, vol. 6(1), pages 1-12, December.
  14. Ansgar Lange & Anne Prenzler & Oliver Bachmann & Roland Linder & Sarah Neubauer & Jan Zeidler & Michael Manns & J.-Matthias von der Schulenburg, 2015. "Regional differences in health care of patients with inflammatory bowel disease in Germany," Health Economics Review, Springer, vol. 5(1), pages 1-11, December.
  15. J.-Matthias Schulenburg & Martin Frank, 2015. "Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(2), pages 113-118, March.
  16. Mike Klora & Jan Zeidler & Roland Linder & Frank Verheyen & J.-Matthias von der Schulenburg, 2015. "Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis -," Health Economics Review, Springer, vol. 5(1), pages 1-9, December.
  17. David Bowles & Andy Zuchandke & Wolfgang Greiner & J.-Matthias Graf von der Schulenburg, 2014. "Entwicklung der Leistungsempfängerzahlen in der Gesetzlichen Pflegeversicherung - Zum Einfluss unterschiedlicher Morbiditätsannahmen auf die Entwicklung der sozialrechtlich anerkannten Pflegebedürftig," Schmollers Jahrbuch : Journal of Applied Social Science Studies / Zeitschrift für Wirtschafts- und Sozialwissenschaften, Duncker & Humblot, Berlin, vol. 134(2), pages 209-236.
  18. Alexander Kuhlmann & Anne Prenzler & Jan Hacker & J-Matthias Graf von der Schulenburg, 2013. "Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system," Health Economics Review, Springer, vol. 3(1), pages 1-17, December.
  19. Alexander Kuhlmann & Ulrike Theidel & Mathias Pletz & J-Matthias von der Schulenburg, 2012. "Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany," Health Economics Review, Springer, vol. 2(1), pages 1-13, December.
  20. Linertová, Renata & Serrano-Aguilar, Pedro & Posada-de-la-Paz, Manuel & Hens-Pérez, Manuel & Kanavos, Panos & Taruscio, Domenica & Schieppati, Arrigo & Stefanov, Rumen & Péntek, Márta & Delgado, Claud, 2012. "Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study," Health Policy, Elsevier, vol. 108(1), pages 19-26.
  21. Christian Thomann & Razvan Pascalau & J.-Matthias Graf von der Schulenburg, 2012. "Corporate Management of Highly Dynamic Risks: Evidence from the Demand for Terrorism Insurance in Germany," The Geneva Risk and Insurance Review, Palgrave Macmillan;International Association for the Study of Insurance Economics (The Geneva Association), vol. 37(1), pages 57-82, March.
  22. J-Matthias Graf von der Schulenburg & Sebastian Braun, 2011. "Greetings from the Editors," Health Economics Review, Springer, vol. 1(1), pages 1-2, December.
  23. J.-Matthias Graf von der Schulenburg & Wolfgang Greiner, 2011. "Letter from the editors," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(1), pages 1-1, February.
  24. Jan-Marc Hodek & J-Matthias von der Schulenburg & Thomas Mittendorf, 2011. "Measuring economic consequences of preterm birth - Methodological recommendations for the evaluation of personal burden on children and their caregivers," Health Economics Review, Springer, vol. 1(1), pages 1-10, December.
  25. Kathrin Damm & Jana Schubert & J-Matthias von der Schulenburg, 2011. "Promoting vaccinations - an analysis of measures taken by German statutory health insurers," Health Economics Review, Springer, vol. 1(1), pages 1-6, December.
  26. J.-Matthias Graf von der Schulenburg, 2010. "EJHE has an official impact factor of 1.337," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(5), pages 435-435, October.
  27. Sebastian Reddemann & Tobias Basse & Johann-Matthias Graf von der Schulenburg, 2010. "On the Impact of the Financial Crisis on the Dividend Policy of the European Insurance Industry," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 35(1), pages 53-62, January.
  28. J.-Matthias Schulenburg & Anne Prenzler & Willemien Schurer, 2010. "Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(1), pages 21-26, January.
  29. Andy Zuchandke & Sebastian Reddemann & Simone Krummaker & J.-Matthias Graf von der Schulenburg, 2010. "Impact of the Introduction of the Social Long-Term Care Insurance in Germany on Financial Security Assessment in Case of Long-Term Care Need*," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 35(4), pages 626-643, October.
  30. Michael Sonnenholzner & Sebastian Friese & J.-Matthias Graf v. d. Schulenburg, 2009. "Reinsurance Brokers and Advice Quality: Is There a Need for Regulation?," The Geneva Risk and Insurance Review, Palgrave Macmillan;International Association for the Study of Insurance Economics (The Geneva Association), vol. 34(1), pages 20-46, June.
  31. J.-Matthias Graf von der Schulenburg & Wolfgang Greiner, 2007. "Editor’s note," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 8(3), pages 179-179, September.
  32. Schulenburg J.-Matthias Graf von der & Vauth Christoph, 2007. "Nach welchen ökonomischen Methoden sollten Gesundheitsleistungen in Deutschland evaluiert werden? / According to Which Economic Methods Should Health Care Services Become Evaluated in Germany?," Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik), De Gruyter, vol. 227(5-6), pages 787-806, October.
  33. Werner Kulp & J.-M. Schulenburg & Wolfgang Greiner, 2005. "Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(4), pages 317-321, December.
  34. W. Greiner & C. Claes & J. J. V. Busschbach & J.-M. Schulenburg, 2005. "Validating the EQ-5D with time trade off for the German population," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(2), pages 124-130, June.
  35. J.-Matthias Schulenburg, 2005. "German health care system in transition," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(2), pages 183-187, June.
  36. J.-Matthias Graf Schulenburg, 2002. "Commentary," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 3(2), pages 138-138, June.
  37. Ruof, Jorg & Mittendorf, Thomas & Pirk, Olaf & Graf von der Schulenburg, J. -Matthias, 2002. "Diffusion of innovations: treatment of Alzheimer's disease in Germany," Health Policy, Elsevier, vol. 60(1), pages 59-66, April.
  38. J.‐Matthias Graf v. d. Schulenburg, 1993. "Bonus options in health insurance by Peter Zweifel. Awer Academic Publishers, Dordrecht, 1992. No. of ges: xii + 141. ISBN 0‐7923‐1722‐X," Health Economics, John Wiley & Sons, Ltd., vol. 2(1), pages 81-82, April.
  39. Eric Briys & Harris Schlesinger & J.-Matthias Graf v. d. Schulenburg, 1991. "Reliability of Risk Management: Market Insurance, Self-Insurance and Self-Protection Reconsidered," The Geneva Risk and Insurance Review, Palgrave Macmillan;International Association for the Study of Insurance Economics (The Geneva Association), vol. 16(1), pages 45-58, June.
  40. Friedrich Breyer & J.‐Matthias Graf V. D. Schulenburg**, 1987. "Voting on Social Security: The Family as Decision‐Making Unit," Kyklos, Wiley Blackwell, vol. 40(4), pages 529-547, November.

Books

  1. Stefan Helber & Michael Breitner & Daniel Rösch & Cornelia Schön & Johann-Matthias Graf von der Schu (ed.), 2014. "Operations Research Proceedings 2012," Operations Research Proceedings, Springer, edition 127, number 978-3-319-00795-3, April.

Editorship

  1. Health Economics Review, Springer.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Blog mentions

As found by EconAcademics.org, the blog aggregator for Economics research:
  1. Doug Coyle & Isabelle Durand-Zaleski & Jasmine Farrington & Louis Garrison & Johann-Matthias Graf von der Schulenburg & Wolfgang Greiner & Louise Longworth & Aurélie Meunier & Anne-Sophie Moutié & Ste, 2020. "HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(9), pages 1421-1437, December.

    Mentioned in:

    1. Chris Sampson’s journal round-up for 9th November 2020
      by Chris Sampson in The Academic Health Economists' Blog on 2020-11-09 12:00:00

Working papers

  1. F.S. Mennini & A. Marcellusi & J.M. Graf von Der Schulenburg & A. Gray & Pierre Lévy & P. Sciattella & M. Soro & G. Staffiero & J. Zeidler & A. Maggioni & R. E. Schmieder, 2015. "Cost of poor adherence to anti-hypertensive therapy in five European countries," Post-Print hal-01616348, HAL.

    Cited by:

    1. Zijing Pan & Wanchun Xu & Zhong Li & Chengzhong Xu & Fangfang Lu & Pei Zhang & Liang Zhang & Ting Ye, 2020. "Trajectories of Outpatient Service Utilisation of Hypertensive Patients in Tertiary Hospitals in China," IJERPH, MDPI, vol. 17(3), pages 1-15, January.
    2. Klaus Mann & Michael Möcker & Joachim Grosser, 2019. "Adherence to long-term prophylactic treatment: microeconomic analysis of patients’ behavior and the impact of financial incentives," Health Economics Review, Springer, vol. 9(1), pages 1-10, December.
    3. Maria Teresa Greco & Antonio Giampiero Russo, 2017. "Valutazione del modello CREG utilizzato dalla ATS della Citt? Metropolitana di Milano per la gestione delle malattie croniche nella medicina generale," MECOSAN, FrancoAngeli Editore, vol. 2017(101), pages 31-50.

  2. Neubauer, Sarah & Zeidler, Jan & Lange, Ansgar & Graf von der Schulenburg, J.-Matthias, 2014. "Grundlagen und Methoden von GKV-Routinedatenstudien," Hannover Economic Papers (HEP) dp-534, Leibniz Universität Hannover, Wirtschaftswissenschaftliche Fakultät.

    Cited by:

    1. Kreis, Kristine & Neubauer, Sarah & Klora, Mike & Lange, Ansgar & Zeidler, Jan, 2016. "Status and perspectives of claims data analyses in Germany—A systematic review," Health Policy, Elsevier, vol. 120(2), pages 213-226.
    2. Jan Breitkreuz & Gabriela Brückner & Jan Pablo Burgard & Joscha Krause & Ralf Münnich & Helmut Schröder & Katrin Schüssel, 2019. "Schätzung kleinräumiger Krankheitshäufigkeiten für die deutsche Bevölkerung anhand von Routinedaten am Beispiel von Typ-2-Diabetes [Estimation of regional diabetes type 2 prevalence in the German p," AStA Wirtschafts- und Sozialstatistisches Archiv, Springer;Deutsche Statistische Gesellschaft - German Statistical Society, vol. 13(1), pages 35-72, April.
    3. Ehing, Daniel & Hagist, Christian, 2015. "Dementia vs. somatic conditions in the German LTC-system: A longitudinal analysis," FZG Discussion Papers 56, University of Freiburg, Research Center for Generational Contracts (FZG).

Articles

  1. Doug Coyle & Isabelle Durand-Zaleski & Jasmine Farrington & Louis Garrison & Johann-Matthias Graf von der Schulenburg & Wolfgang Greiner & Louise Longworth & Aurélie Meunier & Anne-Sophie Moutié & Ste, 2020. "HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(9), pages 1421-1437, December.

    Cited by:

    1. Wettstein, Dominik J. & Boes, Stefan, 2022. "How value-based policy interventions influence price negotiations for new medicines: An experimental approach and initial evidence," Health Policy, Elsevier, vol. 126(2), pages 112-121.
    2. Daniel Gallacher & Nigel Stallard & Peter Kimani & Elvan Gökalp & Juergen Branke, 2022. "Development of a model to demonstrate the impact of National Institute of Health and Care Excellence cost‐effectiveness assessment on health utility for targeted medicines," Health Economics, John Wiley & Sons, Ltd., vol. 31(2), pages 417-430, February.

  2. Dirk Wrede & Tino Stegen & Johann-Matthias Schulenburg, 2020. "Affirmative and silent cyber coverage in traditional insurance policies: Qualitative content analysis of selected insurance products from the German insurance market," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 45(4), pages 657-689, October.

    Cited by:

    1. Martin Eling & Michael McShane & Trung Nguyen, 2021. "Cyber risk management: History and future research directions," Risk Management and Insurance Review, American Risk and Insurance Association, vol. 24(1), pages 93-125, March.

  3. Thomas R. Staab & Miriam Walter & Sonja Mariotti Nesurini & Charalabos-Markos Dintsios & J.-Matthias Graf von der Schulenburg & Volker E. Amelung & Jörg Ruof, 2018. "“Market withdrawals” of medicines in Germany after AMNOG: a comparison of HTA ratings and clinical guideline recommendations," Health Economics Review, Springer, vol. 8(1), pages 1-11, December.

    Cited by:

    1. Melanie Büssgen & Tom Stargardt, 2023. "Does health technology assessment compromise access to pharmaceuticals?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(3), pages 437-451, April.

  4. Kristina Ludwig & J.-Matthias Graf von der Schulenburg & Wolfgang Greiner, 2018. "German Value Set for the EQ-5D-5L," PharmacoEconomics, Springer, vol. 36(6), pages 663-674, June.

    Cited by:

    1. Thomas Rückschloß & Julius Moratin & Sven Zittel & Maximilian Pilz & Christoph Roser & Michael Engel & Christian Freudlsperger & Jürgen Hoffmann & Oliver Ristow, 2021. "Influence of Preventive Tooth Extractions on Quality of Life in Patients with Antiresorptive Intake—A Prospective Longitudinal Study," IJERPH, MDPI, vol. 18(21), pages 1-10, November.
    2. Elena Olariu & Wael Mohammed & Yemi Oluboyede & Raluca Caplescu & Ileana Gabriela Niculescu-Aron & Marian Sorin Paveliu & Luke Vale, 2023. "EQ-5D-5L: a value set for Romania," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(3), pages 399-412, April.
    3. Kelleher, Dan & Barry, Luke & Hobbins, Anna & O'Neill, Stephen & Doherty, Edel & O'Neill, Ciaran, 2020. "Examining the transnational health preferences of a group of Eastern European migrants relative to a European host population using the EQ-5D-5L," Social Science & Medicine, Elsevier, vol. 246(C).
    4. Koonal K. Shah & Juan Manuel Ramos-Goñi & Simone Kreimeier & Nancy J. Devlin, 2020. "An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(7), pages 1091-1103, September.
    5. Kristina Burström & Fitsum Sebsibe Teni & Ulf-G. Gerdtham & Reiner Leidl & Gert Helgesson & Ola Rolfson & Martin Henriksson, 2020. "Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States," PharmacoEconomics, Springer, vol. 38(8), pages 839-856, August.
    6. Hobbins, Anna P. & Barry, Luke & Kelleher, Dan & Shah, Koonal & Devlin, Nancy & Ramos Goni, Juan Manuel & O’Neill, Ciaran, 2020. "Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in Ireland," Health Policy, Elsevier, vol. 124(6), pages 639-646.
    7. Thomas Grochtdreis & Susanne Röhr & Franziska U. Jung & Michaela Nagl & Anna Renner & Anette Kersting & Steffi G. Riedel-Heller & Hans-Helmut König & Judith Dams, 2021. "Health Care Services Utilization and Health-Related Quality of Life of Syrian Refugees with Post-Traumatic Stress Symptoms in Germany (the Sanadak Trial)," IJERPH, MDPI, vol. 18(7), pages 1-13, March.
    8. Menyfah Q. Alanazi & Waleed Abdelgawwad & Thamer A. Almangour & Fatma Mostafa & Mona Almuheed, 2023. "Impact of COVID-19 on the Health-Related Quality of Life of Patients during Infection and after Recovery in Saudi Arabia," IJERPH, MDPI, vol. 20(6), pages 1-14, March.
    9. Christina Pichler & Johanna Freidl & Michael Bischof & Martin Kiem & Renate Weisböck-Erdheim & Daniela Huber & Gabriella Squarra & Paul Clemens Murschetz & Arnulf Hartl, 2022. "Mountain Hiking vs. Forest Therapy: A Study Protocol of Novel Types of Nature-Based Intervention," IJERPH, MDPI, vol. 19(7), pages 1-17, March.
    10. Chen-Wei Pan & Jun-Yi He & Yan-Bo Zhu & Chun-Hua Zhao & Nan Luo & Pei Wang, 2023. "Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(6), pages 885-893, August.
    11. Finch, Aureliano Paolo & Meregaglia, Michela & Ciani, Oriana & Roudijk, Bram & Jommi, Claudio, 2022. "An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration," Social Science & Medicine, Elsevier, vol. 292(C).
    12. Meg Perry-Duxbury & Sebastian Himmler & Job Exel & Werner Brouwer, 2023. "Willingness to pay for health gains from an international integrated early warning system for infectious disease outbreaks," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(6), pages 967-986, August.
    13. Lan Gao & Wei Luo & Utsana Tonmukayakul & Marj Moodie & Gang Chen, 2021. "Mapping MacNew Heart Disease Quality of Life Questionnaire onto country-specific EQ-5D-5L utility scores: a comparison of traditional regression models with a machine learning technique," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(2), pages 341-350, March.
    14. Sullivan, Trudy & Hansen, Paul & Ombler, Franz & Derrett, Sarah & Devlin, Nancy, 2020. "A new tool for creating personal and social EQ-5D-5L value sets, including valuing ‘dead’," Social Science & Medicine, Elsevier, vol. 246(C).
    15. Thomas Grochtdreis & Hans-Helmut König & Anju Devianee Keetharuth & Jürgen Gallinat & Alexander Konnopka & Holger Schulz & Martin Lambert & Anne Karow & Judith Dams, 2023. "Psychometric evaluation of the German version of the Recovering Quality of Life (ReQoL) measures in patients with affective disorders," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(4), pages 499-512, June.
    16. Daniela Huber & Michaela Mayr & Arnulf Hartl & Sandra Sittenthaler & Eva Traut-Mattausch & Renate Weisböck-Erdheim & Johanna Freidl, 2022. "Sustainability of Hiking in Combination with Coaching in Cardiorespiratory Fitness and Quality of Life," IJERPH, MDPI, vol. 19(7), pages 1-19, March.

  5. Katharina Schmidt & Ana Babac & Frédéric Pauer & Kathrin Damm & J-Matthias von der Schulenburg, 2016. "Measuring patients’ priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks," Health Economics Review, Springer, vol. 6(1), pages 1-11, December.

    Cited by:

    1. Murad, C.A. & Bellinello, M.M. & Silva, A.J. & Netto, A. Caminada & de Souza, G.F.M. & Nabeta, S.I., 2022. "A novel methodology employed for ranking and consolidating performance indicators in holding companies with multiple power plants based on multi-criteria decision-making method," Operations Research Perspectives, Elsevier, vol. 9(C).
    2. Anik, Md Asif Hasan & Sadeek, Soumik Nafis & Hossain, Moinul & Kabir, Shafquat, 2020. "A framework for involving the young generation in transportation planning using social media and crowd sourcing," Transport Policy, Elsevier, vol. 97(C), pages 1-18.
    3. Tim Gruchmann & Annika Mies & Thomas Neukirchen & Stefan Gold, 2021. "Tensions in sustainable warehousing: including the blue-collar perspective on automation and ergonomic workplace design," Journal of Business Economics, Springer, vol. 91(2), pages 151-178, March.

  6. A. Kuhlmann & T. Schmidt & M. Treskova & J. López-Bastida & R. Linertová & J. Oliva-Moreno & P. Serrano-Aguilar & M. Posada-de-la-Paz & P. Kanavos & D. Taruscio & A. Schieppati & G. Iskrov & M. Péntek, 2016. "Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 79-87, April.

    Cited by:

    1. Valentin Brodszky & Zsuzsanna Beretzky & Petra Baji & Fanni Rencz & Márta Péntek & Alexandru Rotar & Konstantin Tachkov & Susanne Mayer & Judit Simon & Maciej Niewada & Rok Hren & László Gulácsi, 2019. "Cost-of-illness studies in nine Central and Eastern European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(1), pages 155-172, June.
    2. Alvaro Rafael Villar Hernández & Fernando Molero Alonso & Álvaro Jesús Aguado Marín & Manuel Posada de la Paz, 2022. "Transcultural Validation of a Spanish Version of the Quality of Life in Epidermolysis Bullosa Questionnaire," IJERPH, MDPI, vol. 19(12), pages 1-11, June.
    3. Takeya Adachi & Ayman W. El-Hattab & Ritu Jain & Katya A. Nogales Crespo & Camila I. Quirland Lazo & Maurizio Scarpa & Marshall Summar & Duangrurdee Wattanasirichaigoon, 2023. "Enhancing Equitable Access to Rare Disease Diagnosis and Treatment around the World: A Review of Evidence, Policies, and Challenges," IJERPH, MDPI, vol. 20(6), pages 1-37, March.
    4. Michela Meregaglia & Elena Nicod & Michael Drummond, 2023. "The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(7), pages 1151-1216, September.
    5. Marialuisa Saviano & Sergio Barile & Francesco Caputo & Mattia Lettieri & Stefania Zanda, 2019. "From Rare to Neglected Diseases: A Sustainable and Inclusive Healthcare Perspective for Reframing the Orphan Drugs Issue," Sustainability, MDPI, vol. 11(5), pages 1-21, March.
    6. López-Bastida, J. & Ramos-Goñi, J.M. & Aranda-Reneo, I. & Trapero-Bertran, M. & Kanavos, P. & Rodriguez Martin, B., 2019. "Using a stated preference discrete choice experiment to assess societal value from the perspective of decision-makers in Europe. Does it work for rare diseases?," Health Policy, Elsevier, vol. 123(2), pages 152-158.
    7. Yllka Kodra & Marianna Cavazza & Marta de Santis & Andrea Guala & Maria-Elena Liverani & Patrizio Armeni & Maura Masini & Domenica Taruscio, 2020. "Social Economic Costs, Health-Related Quality of Life and Disability in Patients with Cri Du Chat Syndrome," IJERPH, MDPI, vol. 17(16), pages 1-14, August.
    8. Isaac Aranda-Reneo & Luz María Peña-Longobardo & Juan Oliva-Moreno & Svenja Litzkendorf & Isabelle Durand-Zaleski & Eduardo F. Tizzano & Julio López-Bastida, 2020. "The Burden of Spinal Muscular Atrophy on Informal Caregivers," IJERPH, MDPI, vol. 17(23), pages 1-12, December.
    9. Javier Güeita-Rodriguez & Pilar Famoso-Pérez & Jaime Salom-Moreno & Pilar Carrasco-Garrido & Jorge Pérez-Corrales & Domingo Palacios-Ceña, 2020. "Challenges Affecting Access to Health and Social Care Resources and Time Management among Parents of Children with Rett Syndrome: A Qualitative Case Study," IJERPH, MDPI, vol. 17(12), pages 1-16, June.
    10. Alicia Aurora Rodríguez & Óscar Martínez & Imanol Amayra & Juan Francisco López-Paz & Mohammad Al-Rashaida & Esther Lázaro & Patricia Caballero & Manuel Pérez & Sarah Berrocoso & Maitane García & Paul, 2021. "Diseases Costs and Impact of the Caring Role on Informal Carers of Children with Neuromuscular Disease," IJERPH, MDPI, vol. 18(6), pages 1-16, March.
    11. Alicia Aurora Rodríguez & Imanol Amayra & Juan Francisco López-Paz & Oscar Martínez & Maitane García & Mónika Salgueiro & Mohammad Al-Rashaida & Paula María Luna & Paula Pérez-Nuñez & Nicole Passi & I, 2022. "The Role of Associations in Reducing the Emotional and Financial Impact on Parents Caring for Children with Duchenne Muscular Dystrophy: A Cross-Cultural Study," IJERPH, MDPI, vol. 19(19), pages 1-15, September.
    12. Patrizio Armeni & Marianna Cavazza & Entela Xoxi & Domenica Taruscio & Yllka Kodra, 2021. "Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A Proposal," IJERPH, MDPI, vol. 18(3), pages 1-18, January.
    13. Petra Baji & Dominik Golicki & Valentina Prevolnik-Rupel & Werner B. F. Brouwer & Zsombor Zrubka & László Gulácsi & Márta Péntek, 2019. "The burden of informal caregiving in Hungary, Poland and Slovenia: results from national representative surveys," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(1), pages 5-16, June.
    14. Luz María Peña-Longobardo & Isaac Aranda-Reneo & Juan Oliva-Moreno & Svenja Litzkendorf & Isabelle Durand-Zaleski & Eduardo Tizzano & Julio López-Bastida, 2020. "The Economic Impact and Health-Related Quality of Life of Spinal Muscular Atrophy. An Analysis across Europe," IJERPH, MDPI, vol. 17(16), pages 1-12, August.

  7. Ulrike Theidel & J-Matthias Graf von der Schulenburg, 2016. "Benefit assessment in Germany: implications for price discounts," Health Economics Review, Springer, vol. 6(1), pages 1-12, December.

    Cited by:

    1. Wettstein, Dominik J. & Boes, Stefan, 2022. "How value-based policy interventions influence price negotiations for new medicines: An experimental approach and initial evidence," Health Policy, Elsevier, vol. 126(2), pages 112-121.
    2. Böhler, Yvonne-Beatrice & Lamping, Christian & Wichardt, Philipp C., 2019. "Pharmaceutical prices: The impact of the launch strategy. An analysis of German data," Kiel Working Papers 2141, Kiel Institute for the World Economy (IfW Kiel).
    3. Yvonne-Beatrice Böhler & Christian Lamping & Philipp Christoph Wichard & Philipp Christoph Wichardt, 2019. "Pharmaceutical Prices: The Impact of the Launch Strategy - An Analysis of German Data," CESifo Working Paper Series 7879, CESifo.

  8. J.-Matthias Schulenburg & Martin Frank, 2015. "Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(2), pages 113-118, March.

    Cited by:

    1. Bardey, David & De Donder , Philippe & Zaporozhets , Vera, 2024. "Economic Incentives to Develop and to Use Diagnostic Tests a Literature Review," Documentos CEDE 21024, Universidad de los Andes, Facultad de Economía, CEDE.
    2. Manuel Melo Mateus & Margarida Catalão-Lopes & Rui Portugal, 2023. "Survival analysis of cancer patients in Portugal following the reference centre model implementation," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(2), pages 157-168, March.

  9. Mike Klora & Jan Zeidler & Roland Linder & Frank Verheyen & J.-Matthias von der Schulenburg, 2015. "Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis -," Health Economics Review, Springer, vol. 5(1), pages 1-9, December.

    Cited by:

    1. Hsing-Jung Li & Chao-Chan Kuo & Yi-Chien Yao & Ching-Hong Tsai & Philip C Chow & Ying-Chun Li, 2018. "Outpatient rehabilitation resources and medical expenditure in children with attention-deficit hyperactivity disorder in Taiwan," PLOS ONE, Public Library of Science, vol. 13(6), pages 1-10, June.

  10. Alexander Kuhlmann & Ulrike Theidel & Mathias Pletz & J-Matthias von der Schulenburg, 2012. "Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany," Health Economics Review, Springer, vol. 2(1), pages 1-13, December.

    Cited by:

    1. Elizabeth T Cafiero-Fonseca & Andrew Stawasz & Sydney T Johnson & Reiko Sato & David E Bloom, 2017. "The full benefits of adult pneumococcal vaccination: A systematic review," PLOS ONE, Public Library of Science, vol. 12(10), pages 1-23, October.
    2. Shu-ling Hoshi & Masahide Kondo & Ichiro Okubo, 2015. "Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the ," PLOS ONE, Public Library of Science, vol. 10(10), pages 1-16, October.
    3. Jung Yeon Heo & Yu Bin Seo & Won Suk Choi & Jacob Lee & Ji Yun Noh & Hye Won Jeong & Woo Joo Kim & Min Ja Kim & Hee Young Lee & Joon Young Song, 2017. "Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea," PLOS ONE, Public Library of Science, vol. 12(5), pages 1-17, May.
    4. Ulrike Kuchenbecker & Daniela Chase & Anika Reichert & Julia Schiffner-Rohe & Mark Atwood, 2018. "Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany," PLOS ONE, Public Library of Science, vol. 13(5), pages 1-23, May.

  11. Linertová, Renata & Serrano-Aguilar, Pedro & Posada-de-la-Paz, Manuel & Hens-Pérez, Manuel & Kanavos, Panos & Taruscio, Domenica & Schieppati, Arrigo & Stefanov, Rumen & Péntek, Márta & Delgado, Claud, 2012. "Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study," Health Policy, Elsevier, vol. 108(1), pages 19-26.

    Cited by:

    1. Julio López-Bastida & Renata Linertová & Juan Oliva-Moreno & Manuel Posada-de-la-Paz & Pedro Serrano-Aguilar & Panos Kanavos & Domenica Taruscio & Arrigo Schieppati & Georgi Iskrov & Petra Baji & Clau, 2016. "Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 99-108, April.
    2. Julio López-Bastida & Renata Linertová & Juan Oliva-Moreno & Pedro Serrano-Aguilar & Manuel Posada-de-la-Paz & Panos Kanavos & Domenica Taruscio & Arrigo Schieppati & Georgi Iskrov & Márta Péntek & Cl, 2016. "Social/economic costs and health-related quality of life in patients with scleroderma in Europe," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 109-117, April.
    3. Georgi Iskrov & Itziar Astigarraga & Rumen Stefanov & Julio López-Bastida & Renata Linertová & Juan Oliva-Moreno & Pedro Serrano-Aguilar & Manuel Posada-de-la-Paz & Arrigo Schieppati & Domenica Tarusc, 2016. "Social/economic costs and health-related quality of life in patients with histiocytosis in Europe," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 67-78, April.
    4. Angelis, Aris & Tordrup, David & Kanavos, Panos, 2015. "Socio-economic burden of rare diseases: A systematic review of cost of illness evidence," Health Policy, Elsevier, vol. 119(7), pages 964-979.
    5. Márta Péntek & László Gulácsi & Valentin Brodszky & Petra Baji & Imre Boncz & Gábor Pogány & Julio López-Bastida & Renata Linertová & Juan Oliva-Moreno & Pedro Serrano-Aguilar & Manuel Posada-de-la-Pa, 2016. "Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 89-98, April.
    6. Patrizio Armeni & Marianna Cavazza & Entela Xoxi & Domenica Taruscio & Yllka Kodra, 2021. "Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A Proposal," IJERPH, MDPI, vol. 18(3), pages 1-18, January.

  12. Christian Thomann & Razvan Pascalau & J.-Matthias Graf von der Schulenburg, 2012. "Corporate Management of Highly Dynamic Risks: Evidence from the Demand for Terrorism Insurance in Germany," The Geneva Risk and Insurance Review, Palgrave Macmillan;International Association for the Study of Insurance Economics (The Geneva Association), vol. 37(1), pages 57-82, March.

    Cited by:

    1. Simone Krummaker, 2019. "Firm's demand for insurance: An explorative approach," Risk Management and Insurance Review, American Risk and Insurance Association, vol. 22(3), pages 279-301, September.
    2. Jean-François Outreville, 2014. "The Meaning of Risk? Insights from The Geneva Risk and Insurance Review," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 39(4), pages 768-781, October.
    3. Christian Biener & Martin Eling, 2013. "Recent Research Developments Affecting Nonlife Insurance—The CAS Risk Premium Project 2012 Update," Risk Management and Insurance Review, American Risk and Insurance Association, vol. 16(2), pages 219-231, September.

  13. Jan-Marc Hodek & J-Matthias von der Schulenburg & Thomas Mittendorf, 2011. "Measuring economic consequences of preterm birth - Methodological recommendations for the evaluation of personal burden on children and their caregivers," Health Economics Review, Springer, vol. 1(1), pages 1-10, December.

    Cited by:

    1. Caroline Wilson & Catherine Cook, 2018. "Ambiguous loss and post‐traumatic growth: Experiences of mothers whose school‐aged children were born extremely prematurely," Journal of Clinical Nursing, John Wiley & Sons, vol. 27(7-8), pages 1627-1639, April.
    2. Hosein Dalili & Mohaddese Fallahi & Saeid Moradi & Fatemeh Nayeri & Mamak Shariat & Arash Rashidian, 2014. "Clinical outcome and cost of treatment and care for neonates less than 1000 grams admitted to Vali-e ASR Hospital," Health Economics Review, Springer, vol. 4(1), pages 1-6, December.
    3. Christabel C Enweronu-Laryea & Hilary D Andoh & Audrey Frimpong-Barfi & Francis M Asenso-Boadi, 2018. "Parental costs for in-patient neonatal services for perinatal asphyxia and low birth weight in Ghana," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-14, October.

  14. Sebastian Reddemann & Tobias Basse & Johann-Matthias Graf von der Schulenburg, 2010. "On the Impact of the Financial Crisis on the Dividend Policy of the European Insurance Industry," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 35(1), pages 53-62, January.

    Cited by:

    1. Rihanat Idowu Abdulkadir & Nur Adiana Hiau Abdullah & Wong Woei-Chyuan, 2015. "Dividend Policy Changes in The Pre-, Mid-, and Post-Financial Crisis: Evidence from The Nigerian Stock Market," Asian Academy of Management Journal of Accounting and Finance (AAMJAF), Penerbit Universiti Sains Malaysia, vol. 11(2), pages 103-126.
    2. Basse, Tobias & Klein, Tony & Vigne, Samuel A. & Wegener, Christoph, 2021. "U.S. stock prices and the dot.com-bubble: Can dividend policy rescue the efficient market hypothesis?," Journal of Corporate Finance, Elsevier, vol. 67(C).
    3. Al-Malkawi, Husam-Aldin Nizar & Bhatti, M. Ishaq & Magableh, Sohail I., 2014. "On the dividend smoothing, signaling and the global financial crisis," Economic Modelling, Elsevier, vol. 42(C), pages 159-165.

  15. J.-Matthias Schulenburg & Anne Prenzler & Willemien Schurer, 2010. "Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(1), pages 21-26, January.

    Cited by:

    1. Lianne Barnieh & Fiona Clement & Anthony Harris & Marja Blom & Cam Donaldson & Scott Klarenbach & Don Husereau & Diane Lorenzetti & Braden Manns, 2014. "A Systematic Review of Cost-Sharing Strategies Used within Publicly-Funded Drug Plans in Member Countries of the Organisation for Economic Co-Operation and Development," PLOS ONE, Public Library of Science, vol. 9(3), pages 1-10, March.

  16. Andy Zuchandke & Sebastian Reddemann & Simone Krummaker & J.-Matthias Graf von der Schulenburg, 2010. "Impact of the Introduction of the Social Long-Term Care Insurance in Germany on Financial Security Assessment in Case of Long-Term Care Need*," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 35(4), pages 626-643, October.

    Cited by:

    1. Rong Peng & Xueqin Deng & Yinghua Xia & Bei Wu, 2022. "Assessing the Sustainability of Long-Term Care Insurance Systems Based on a Policy–Population–Economy Complex System: The Case Study of China," IJERPH, MDPI, vol. 19(11), pages 1-17, May.
    2. Johannes Geyer & Thorben Korfhage, 2015. "Long-Term Care Reform and the Labor Supply of Household Members: Evidence from a Quasi-Experiment," SOEPpapers on Multidisciplinary Panel Data Research 785, DIW Berlin, The German Socio-Economic Panel (SOEP).
    3. Sergi Jiménez‐Martín & José M. Labeaga‐Azcona & Cristina Vilaplana‐Prieto, 2016. "Interactions between Private Health and Long‐term Care Insurance and the Effects of the Crisis: Evidence for Spain," Health Economics, John Wiley & Sons, Ltd., vol. 25(S2), pages 159-179, November.
    4. J. Iñaki De La Peña & M. Cristina Fernández-Ramos & Asier Garayeta, 2021. "Cost-Free LTC Model Incorporated into Private Pension Schemes," IJERPH, MDPI, vol. 18(5), pages 1-16, February.
    5. Pieter Bakx & Claudine de Meijer & Frederik Schut & Eddy van Doorslaer, 2015. "Going Formal or Informal, Who Cares? The Influence of Public Long‐Term Care Insurance," Health Economics, John Wiley & Sons, Ltd., vol. 24(6), pages 631-643, June.

  17. Michael Sonnenholzner & Sebastian Friese & J.-Matthias Graf v. d. Schulenburg, 2009. "Reinsurance Brokers and Advice Quality: Is There a Need for Regulation?," The Geneva Risk and Insurance Review, Palgrave Macmillan;International Association for the Study of Insurance Economics (The Geneva Association), vol. 34(1), pages 20-46, June.

    Cited by:

    1. Annette Hofmann & Julia K. Neumann & David Pooser, 2018. "Plea for Uniform Regulation and Challenges of Implementing the New Insurance Distribution Directive," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 43(4), pages 740-769, October.
    2. J François Outreville, 2010. "The Geneva Risk and Insurance Review 2009: In Quest of Behavioural Insurance," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 35(3), pages 484-497, July.

  18. Werner Kulp & J.-M. Schulenburg & Wolfgang Greiner, 2005. "Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(4), pages 317-321, December.

    Cited by:

    1. Marieke Krol & Jocé Papenburg & Marc Koopmanschap & Werner Brouwer, 2011. "Do Productivity Costs Matter?," PharmacoEconomics, Springer, vol. 29(7), pages 601-619, July.

  19. W. Greiner & C. Claes & J. J. V. Busschbach & J.-M. Schulenburg, 2005. "Validating the EQ-5D with time trade off for the German population," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(2), pages 124-130, June.

    Cited by:

    1. Jose Antonio Robles-Zurita & Andrew Briggs & Dikshyanta Rana & Zahidul Quayyum & Keith G. Oldroyd & Uwe Zeymer & Steffen Desch & Suzanne Waha-Thiele & Holger Thiele, 2020. "Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(8), pages 1197-1209, November.
    2. Hildegard Seidl & Matthias Hunger & Reiner Leidl & Christa Meisinger & Rupert Wende & Bernhard Kuch & Rolf Holle, 2015. "Cost-effectiveness of nurse-based case management versus usual care for elderly patients with myocardial infarction: results from the KORINNA study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(6), pages 671-681, July.
    3. Mathieu F. Janssen & A. Simon Pickard & James W. Shaw, 2021. "General population normative data for the EQ-5D-3L in the five largest European economies," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(9), pages 1467-1475, December.
    4. Claudia Schulz & Gisela Büchele & Raphael S. Peter & Dietrich Rothenbacher & Christian Brettschneider & Ulrich C. Liener & Clemens Becker & Kilian Rapp & Hans-Helmut König, 2021. "Health-economic evaluation of collaborative orthogeriatric care for patients with a hip fracture in Germany: a retrospective cohort study using health and long-term care insurance claims data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(6), pages 873-885, August.
    5. Pepijn Vemer & Maureen Rutten-van Mölken, 2013. "The Road Not Taken: Transferability Issues in Multinational Trials," PharmacoEconomics, Springer, vol. 31(10), pages 863-876, October.
    6. Richard Dodel & Svenja Happe & Ines Peglau & Geert Mayer & Jürgen Wasem & Jens-Peter Reese & Guido Giani & Max Geraedts & Claudia Trenkwalder & Wolfgang Oertel & Karin Stiasny-Kolster, 2010. "Health Economic Burden of Patients with Restless Legs Syndrome in a German Ambulatory Setting," PharmacoEconomics, Springer, vol. 28(5), pages 381-393, May.
    7. Raymond Oppong & Billingsley Kaambwa & Jacqueline Nuttall & Kerenza Hood & Richard Smith & Joanna Coast, 2013. "The impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(2), pages 197-209, April.
    8. Anja Schwalm & You-Shan Feng & Jörn Moock & Thomas Kohlmann, 2015. "Differences in EQ-5D-3L health state valuations among patients with musculoskeletal diseases, health care professionals and healthy volunteers," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(8), pages 865-877, November.
    9. Munir A. Khan & Jeff Richardson, 2019. "Is the Validity of Cost Utility Analysis Improved When Utility is Measured by an Instrument with ‘Home-Country’ Weights? Evidence from Six Western Countries," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 145(1), pages 1-15, August.
    10. Carl Tilling & Marieke Kro & Aki Tsuchiya & John Brazier & Job Exel & Werner Brouwer, 2012. "Does the EQ-5D Reflect Lost Earnings?," PharmacoEconomics, Springer, vol. 30(1), pages 47-61, January.
    11. Rodríguez-Míguez, E. & Abellán-Perpiñán, J.M. & Alvarez, X.C. & González, X.M. & Sampayo, A.R., 2016. "The DEP-6D, a new preference-based measure to assess health states of dependency," Social Science & Medicine, Elsevier, vol. 153(C), pages 210-219.
    12. Dirk Müller & Marion Danner & Kerstin Rhiem & Björn Stollenwerk & Christoph Engel & Linda Rasche & Lisa Borsi & Rita Schmutzler & Stephanie Stock, 2018. "Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(3), pages 341-353, April.
    13. Maike Stolz & Christian Albus & Manfred E. Beutel & Hans-Christian Deter & Kurt Fritzsche & Christoph Herrmann-Lingen & Matthias Michal & Katja Petrowski & Joram Ronel & Jobst-Hendrik Schultz & Wolfga, 2023. "Assessment of health-related quality of life in individuals with depressive symptoms: validity and responsiveness of the EQ-5D-3L and the SF-6D," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(8), pages 1297-1307, November.
    14. Eleanor Pullenayegum & Kuhan Perampaladas & Kathryn Gaebel & Brett Doble & Feng Xie, 2015. "Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(8), pages 847-855, November.
    15. Kyra Kneis & Afschin Gandjour, 2009. "Economic evaluation of Sinfrontal®in the treatment of acute maxillary sinusitis in adults," Applied Health Economics and Health Policy, Springer, vol. 7(3), pages 181-191, September.
    16. Daniela Eidt-Koch & Wolfgang Greiner, 2011. "Quality of life results of balloon kyphoplasty versus non surgical management for osteoporotic vertebral fractures in Germany," Health Economics Review, Springer, vol. 1(1), pages 1-7, December.
    17. Hans-Helmut König & Oliver Günther & Matthias Angermeyer & Christiane Roick, 2009. "Utility Assessment in Patients with Mental Disorders," PharmacoEconomics, Springer, vol. 27(5), pages 405-419, May.
    18. A. Konnopka & M. Bödemann & H.-H. König, 2011. "Health burden and costs of obesity and overweight in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(4), pages 345-352, August.
    19. Irina Cleemput, 2010. "A social preference valuations set for EQ-5D health states in Flanders, Belgium," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(2), pages 205-213, April.
    20. Chunmei Wu & Yanhong Gong & Jiang Wu & Shengchao Zhang & Xiaoxv Yin & Xiaoxin Dong & Wenzhen Li & Shiyi Cao & Naomie Mkandawire & Zuxun Lu, 2016. "Chinese Version of the EQ-5D Preference Weights: Applicability in a Chinese General Population," PLOS ONE, Public Library of Science, vol. 11(10), pages 1-16, October.

  20. J.-Matthias Schulenburg, 2005. "German health care system in transition," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(2), pages 183-187, June.

    Cited by:

    1. Reinhard Busse & Tom Stargardt & Jonas Schreyögg, 2005. "Determining the “Health Benefit Basket” of the Statutory Health Insurance scheme in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(1), pages 30-36, November.
    2. Matthias Stoll & Christian Kollan & Frank Bergmann & Johannes Bogner & Gerd Faetkenheuer & Carlos Fritzsche & Kirsten Hoeper & Heinz-August Horst & Jan van Lunzen & Andreas Plettenberg & Stefan Reuter, 2011. "Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort," PLOS ONE, Public Library of Science, vol. 6(9), pages 1-12, September.
    3. Stock, Stephanie Anja Katharina & Redaelli, Marcus & Lauterbach, Karl Wilhelm, 2007. "Disease management and health care reforms in Germany--Does more competition lead to less solidarity?," Health Policy, Elsevier, vol. 80(1), pages 86-96, January.
    4. d'Andria, Diego, 2008. "The Debate on the Sustainability of Social Spending," MPRA Paper 11745, University Library of Munich, Germany.

  21. J.-Matthias Graf Schulenburg, 2002. "Commentary," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 3(2), pages 138-138, June.

    Cited by:

    1. Gerry Boyle & Rory McElligott & Jim O'Leary, 2004. "Public-Private Wage Differentials in Ireland, 1994-2001," Economics Department Working Paper Series n1421004, Department of Economics, National University of Ireland - Maynooth.
    2. Verhaest, Dieter & Omey, Eddy, 2009. "Objective over-education and worker well-being: A shadow price approach," Journal of Economic Psychology, Elsevier, vol. 30(3), pages 469-481, June.

  22. Ruof, Jorg & Mittendorf, Thomas & Pirk, Olaf & Graf von der Schulenburg, J. -Matthias, 2002. "Diffusion of innovations: treatment of Alzheimer's disease in Germany," Health Policy, Elsevier, vol. 60(1), pages 59-66, April.

    Cited by:

    1. Ronja Flemming & Franziska Frölich & Norbert Donner‐Banzhoff & Leonie Sundmacher, 2023. "Diffusion of a new drug among ambulatory physicians—The impact of patient pathways," Health Economics, John Wiley & Sons, Ltd., vol. 32(4), pages 970-982, April.

  23. Eric Briys & Harris Schlesinger & J.-Matthias Graf v. d. Schulenburg, 1991. "Reliability of Risk Management: Market Insurance, Self-Insurance and Self-Protection Reconsidered," The Geneva Risk and Insurance Review, Palgrave Macmillan;International Association for the Study of Insurance Economics (The Geneva Association), vol. 16(1), pages 45-58, June.

    Cited by:

    1. Goldzahl, Léontine, 2017. "Contributions of risk preference, time orientation and perceptions to breast cancer screening regularity," Social Science & Medicine, Elsevier, vol. 185(C), pages 147-157.
    2. Christian Gollier & James Hammitt & Nicolas Treich, 2013. "Risk and choice: A research saga," Journal of Risk and Uncertainty, Springer, vol. 47(2), pages 129-145, October.
    3. Machina, Mark J, 2001. "Payoff Kinks in Preferences over Lotteries," Journal of Risk and Uncertainty, Springer, vol. 23(3), pages 207-260, November.
    4. Heinzel Christoph & Richard Peter, 2021. "Precautionary motives with multiple instruments," Working Papers SMART 21-09, INRAE UMR SMART.
    5. François Pannequin & Anne Corcos & Claude Montmarquette, 2016. "Behavioral foundations of the substitutability between insurance and self-insurance: An experimental study," CIRANO Working Papers 2016s-12, CIRANO.
    6. Courbage, Christophe & Rey, Béatrice & Treich, Nicolas, 2013. "Prevention and precaution," IDEI Working Papers 805, Institut d'Économie Industrielle (IDEI), Toulouse.
    7. Petrolia, Daniel R. & Hwang, Joonghyun & Landry, Craig E. & Coble, Keith H., 2013. "Wind Insurance and Mitigation in the Coastal Zone," Working Papers 160462, Mississippi State University, Department of Agricultural Economics.
    8. Debora Zaparova, 2020. "Mutual or stock insurance: Solidarity in the face of insolvency," Working Papers of BETA 2020-06, Bureau d'Economie Théorique et Appliquée, UDS, Strasbourg.
    9. Romain Gauchon & Karim Barigou, 2021. "Expected utility maximization with stochastically ordered returns," Working Papers hal-03295594, HAL.
    10. Christoph Heinzel & Richard Peter, 2021. "Precautionary motives with multiple instruments [Motifs de précaution en cas de multiples instruments]," Working Papers hal-03484875, HAL.
    11. Biener, Christian & Eling, Martin & Landmann, Andreas & Pradhan, Shailee, 2018. "Can group incentives alleviate moral hazard? The role of pro-social preferences," European Economic Review, Elsevier, vol. 101(C), pages 230-249.
    12. Heinzel, Christoph & Peter, Richard, 2021. "Precautionary motives with multiple instruments," Working Papers 316521, Institut National de la recherche Agronomique (INRA), Departement Sciences Sociales, Agriculture et Alimentation, Espace et Environnement (SAE2).
    13. Constantin ANGHELACHE & Mario G.R. PAGLIACCI & Emilia STANCIU & Cristina SACALÃ, 2016. "Essential aspects regarding the optimal prevention," Romanian Statistical Review Supplement, Romanian Statistical Review, vol. 64(1), pages 38-42, January.
    14. Huang, Rachel J., 2012. "Ambiguity aversion, higher-order risk attitude and optimal effort," Insurance: Mathematics and Economics, Elsevier, vol. 50(3), pages 338-345.
    15. Ozlem Ozdemir, 2007. "Valuation of Self-Insurance and Self-Protection under Ambiguity: Experimental Evidence," Jena Economics Research Papers 2007-034, Friedrich-Schiller-University Jena.
    16. Bensalem, Sarah & Santibáñez, Nicolás Hernández & Kazi-Tani, Nabil, 2020. "Prevention efforts, insurance demand and price incentives under coherent risk measures," Insurance: Mathematics and Economics, Elsevier, vol. 93(C), pages 369-386.
    17. Peter, Richard & Ying, Jie, 2020. "Do you trust your insurer? Ambiguity about contract nonperformance and optimal insurance demand," Journal of Economic Behavior & Organization, Elsevier, vol. 180(C), pages 938-954.

  24. Friedrich Breyer & J.‐Matthias Graf V. D. Schulenburg**, 1987. "Voting on Social Security: The Family as Decision‐Making Unit," Kyklos, Wiley Blackwell, vol. 40(4), pages 529-547, November.

    Cited by:

    1. Konrad, Kai A. & Richter, Wolfram F., 2003. "Zur Berücksichtigung von Kindern bei umlagefinanzierter Alterssicherung [Pay-As-You-Go Financed Social Security and the Role of the Children]," Discussion Papers, Research Unit: Market Processes and Governance SP II 2003-02, WZB Berlin Social Science Center.
    2. Kruse, Agneta & Nyberg, Kristian, 2004. "Pensions and external effects of ageing; effects on distribution," Working Papers 2004:27, Lund University, Department of Economics.
    3. Friedrich Breyer, 2001. "Why Funding Is not a Solution to the "Social Security Crisis"," Discussion Papers of DIW Berlin 254, DIW Berlin, German Institute for Economic Research.
    4. Kai A. Konrad & Gert Wagner, 2000. "Reform of the Public Pension System in Germany," Discussion Papers of DIW Berlin 200, DIW Berlin, German Institute for Economic Research.
    5. Breyer, Friedrich & Craig, Ben, 1997. "Voting on social security: Evidence from OECD countries," European Journal of Political Economy, Elsevier, vol. 13(4), pages 705-724, December.
    6. Henning Bohn, 2009. "A Static Model for Voting on Social Security," CESifo Working Paper Series 2649, CESifo.

Books

  1. Stefan Helber & Michael Breitner & Daniel Rösch & Cornelia Schön & Johann-Matthias Graf von der Schu (ed.), 2014. "Operations Research Proceedings 2012," Operations Research Proceedings, Springer, edition 127, number 978-3-319-00795-3, April.

    Cited by:

    1. Schwarz, Hannes & Bertsch, Valentin & Fichtner, Wolf, 2015. "Two-stage stochastic, large-scale optimization of a decentralized energy system - a residential quarter as case study," Working Paper Series in Production and Energy 10, Karlsruhe Institute of Technology (KIT), Institute for Industrial Production (IIP).
    2. Bertsch, Valentin & Geldermann, Jutta & Lühn, Tobias, 2017. "What drives the profitability of household PV investments, self-consumption and self-sufficiency?," MPRA Paper 78644, University Library of Munich, Germany.
    3. Goeke, Dominik, 2019. "Granular tabu search for the pickup and delivery problem with time windows and electric vehicles," European Journal of Operational Research, Elsevier, vol. 278(3), pages 821-836.
    4. Esther Mohr & Robert Dochow, 2017. "Risk management strategies for finding universal portfolios," Annals of Operations Research, Springer, vol. 256(1), pages 129-147, September.
    5. Bierwirth, Christian & Meisel, Frank, 2015. "A follow-up survey of berth allocation and quay crane scheduling problems in container terminals," European Journal of Operational Research, Elsevier, vol. 244(3), pages 675-689.
    6. Goeke, D. & Schneider, M., 2015. "Routing a Mixed Fleet of Electric and Conventional Vehicles," Publications of Darmstadt Technical University, Institute for Business Studies (BWL) 65939, Darmstadt Technical University, Department of Business Administration, Economics and Law, Institute for Business Studies (BWL).
    7. Goeke, Dominik & Schneider, Michael, 2015. "Routing a mixed fleet of electric and conventional vehicles," European Journal of Operational Research, Elsevier, vol. 245(1), pages 81-99.
    8. Pelletier, Samuel & Jabali, Ola & Laporte, Gilbert & Veneroni, Marco, 2017. "Battery degradation and behaviour for electric vehicles: Review and numerical analyses of several models," Transportation Research Part B: Methodological, Elsevier, vol. 103(C), pages 158-187.
    9. Dahlbeck, Mirko, 2021. "A mixed-integer linear programming approach for the T-row and the multi-bay facility layout problem," European Journal of Operational Research, Elsevier, vol. 295(2), pages 443-462.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 1 paper announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-GER: German Papers (1) 2014-09-25

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Johann Matthias Graf von der Schulenburg should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.